journal article·2025-02

Assembly of a biomimetic copper-based nanocomplex for alleviating hypoxia to enhance cuproptosis against osteosarcoma and lung metastasis

Junyong Wu, Xinyan Hao, Lin Qi, Wenjie Xu, Chi Yin, Yucheng Tang, Pengcheng Sun, Dehua Liao, Xiongbin Hu, Tiantian Tang, Chao Tu, Daxiong Xiang, Zhihong Li

Acta Biomaterialia· Volume 193
Publisher page

Abstract

Osteosarcoma tissues demonstrated elevated expression of proteins (FDX1 and DLAT) integral to cuproptosis in our preliminary study, indicating the potential effectiveness of anti-tumor strategies predicated on this process. Nevertheless, the overexpression of copper export proteins and the challenge of copper ion penetration may contribute to insufficient local copper ion concentration for inducing cuproptosis. Herein, we engineered a biomimetic copper-elesclomol-polyphenol network for the efficient delivery of copper ions and the copper ionophore elesclomol. Simultaneously, we integrated catalase (CAT) to alleviate tumor hypoxia, thereby inducing a greater reliance of tumor cells on aerobic respiration and enhancing cuproptosis sensitivity. In vitro analyses revealed that the nanocomplex exhibited potent cytotoxicity and displayed hallmark characteristics of cuproptosis. In vivo trials further validated targeted tumor accumulation, resulting in the suppression of tumor growth and lung metastasis. An augmentation in the proportion of activated immune cells in both tumor and draining lymph nodes was observed. The improvement of immunosuppressive microenvironment facilitated a synergistic antitumor effect with cuproptosis. The therapeutic efficacy was further evidenced in two osteosarcoma models, highlighting the potential as a safe and effective strategy against osteosarcoma and lung metastasis. STATEMENT OF SIGNIFICANCE: Osteosarcoma tissues exhibit a marked increase in the expression of proteins FDX1 and DLAT, which are crucial for cuproptosis. Moreover, cells that depend on mitochondrial respiration are more susceptible to cuproptosis. Here we developed a biomimetic copper-based nanocomplex to trigger cuproptosis against osteosarcoma and lung metastases. The nanocomplex demonstrated excellent biocompatibility and tumor targeting. Catalase incorporating facilitated oxygen generation within tumor microenvironment and alleviated hypoxia, thereby inducing a greater reliance of tumor cells on aerobic respiration and enhancing cuproptosis sensitivity. Simultaneously, the released Cu-elesclomol complexes induced proteotoxic stress responses and efficiently elicited cuproptosis, leading to increased release of proinflammatory factors and triggering anti-tumor immune activation. Our strategy holds promise for osteosarcoma treatment by inducing cuproptosis and achieving potent tumor suppression.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Extracellular vesicles in disease · Autophagy in Disease and Therapy

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (31)

Show source-provided references
1. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program10.1002/cncr.24121 ↗
2. Immunotherapy for osteosarcoma: fundamental mechanism, rationale, and recent breakthroughs10.1016/j.canlet.2020.12.024 ↗
3. Outcome of patients with recurrent osteosarcoma enrolled in seven phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: learning from the Past to Move Forward10.1200/JCO.2015.65.5381 ↗
4. Advancing therapy for osteosarcoma10.1038/s41571-021-00519-8 ↗
5. Therapeutic targets and emerging treatments in advanced chondrosarcoma10.3390/ijms23031096 ↗
6. Alendronate triggered dual-cascade targeting prodrug nanoparticles for enhanced tumor penetration and STING activation of osteosarcoma10.1002/adfm.202307013 ↗
7. Copper induces cell death by targeting lipoylated TCA cycle proteins10.1126/science.abf0529 ↗
8. Copper homeostasis and cuproptosis in health and disease10.1038/s41392-022-01229-y ↗
9. Cuproptosis: mechanisms and links with cancers10.1186/s12943-023-01732-y ↗
10. Copper metabolism in cell death and autophagy10.1080/15548627.2023.2200554 ↗
11. An enzyme-engineered nonporous copper(I) coordination polymer nanoplatform for cuproptosis-based synergistic cancer therapy10.1002/adma.202204733 ↗
12. Biomedical applications of copper ionophores10.1016/j.ccr.2020.213474 ↗
13. Elesclomol, a copper-transporting therapeutic agent targeting mitochondria: from discovery to its novel applications10.1186/s12967-023-04533-5 ↗
14. Copper-Loaded nanoheterojunction enables superb orthotopic osteosarcoma therapy via oxidative stress and cell cuproptosis10.1021/acsnano.3c04903 ↗
15. High-Throughput design of biocompatible enzyme-based hydrogel microparticles with autonomous movement10.1002/anie.201805661 ↗
16. Fluidity-Guided assembly of Au@Pt on liposomes as a catalase-powered nanomotor for effective cell uptake in cancer cells and plant leaves10.1021/acsnano.2c00327 ↗
17. Direct assembly of metal-phenolic network nanoparticles for biomedical applications10.1002/anie.202312925 ↗
18. Fibronectin-Coated metal-phenolic networks for cooperative tumor chemo-/chemodynamic/immune therapy via enhanced ferroptosis-mediated immunogenic cell death10.1021/acsnano.1c08585 ↗
19. Engineering metal-phenolic networks for enhancing cancer therapy by tumor microenvironment modulation10.1002/wnan.1864 ↗
20. Metal-Polyphenol network-mediated protein encapsulation strategy facilitating the separation of proteins and metabolites in biospecimens
21. Assembly of bioactive nanoparticles via metal-phenolic complexation10.1002/adma.202108624 ↗
22. Bacterial outer membrane vesicles-based therapeutic platform eradicates triple-negative breast tumor by combinational photodynamic/chemo-/immunotherapy
23. Macrophage membrane-biomimetic adhesive polycaprolactone nanocamptothecin for improving cancer-targeting efficiency and impairing metastasis
24. Innovative utilization of cell membrane-coated nanoparticles in precision cancer therapy10.1002/EXP.20230164 ↗
25. Cuproptosis induced by ROS responsive nanoparticles with elesclomol and copper combined with alphaPD-L1 for enhanced cancer immunotherapy
26. A photo-triggered self-accelerated nanoplatform for multifunctional image-guided combination cancer immunotherapy10.1038/s41467-023-40996-2 ↗
27. Biomimetic nanosponges suppress in vivo lethality induced by the whole secreted proteins of pathogenic bacteria10.1002/smll.201804994 ↗
28. Coaxial electrostatic spray-based preparation of localization missile liposomes on a microfluidic chip for targeted treatment of triple-negative breast cancer10.1016/j.ijpharm.2023.123220 ↗
29. Engineering tumor-specific catalytic nanosystem for NIR-II photothermal-augmented and synergistic starvation/chemodynamic nanotherapy10.1186/s40824-022-00317-y ↗
30. Recent advances of redox-responsive nanoplatforms for tumor theranostics10.1016/j.jconrel.2021.02.030 ↗
31. A cooperative nano-CRISPR scaffold potentiates immunotherapy via activation of tumour-intrinsic pyroptosis10.1038/s41467-023-36550-9 ↗